Yuko Shirota

2.2k total citations
47 papers, 1.7k citations indexed

About

Yuko Shirota is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Yuko Shirota has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 17 papers in Pulmonary and Respiratory Medicine and 12 papers in Immunology. Recurrent topics in Yuko Shirota's work include Systemic Lupus Erythematosus Research (10 papers), Vasculitis and related conditions (9 papers) and Systemic Sclerosis and Related Diseases (8 papers). Yuko Shirota is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Vasculitis and related conditions (9 papers) and Systemic Sclerosis and Related Diseases (8 papers). Yuko Shirota collaborates with scholars based in Japan, United States and Czechia. Yuko Shirota's co-authors include Gabor G. Illei, Cheryl Yarboro, Peter E. Lipsky, Dennis M. Klinman, Hidekazu Shirota, Rachel Ettinger, Gary P. Sims, Thomas A. Fleisher, Kazuki Takada and James E. Balow and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuko Shirota

40 papers receiving 1.6k citations

Peers

Yuko Shirota
James Chung United States
Capucine Daridon Germany
Marc Ittah France
Şule Yavuz Türkiye
Venkat Reddy United Kingdom
María Francisca González‐Escribano Spain
Hideki Amuro Japan
Jacob Aelion United States
Cornelia M. Weyand United States
Jens Thiel Germany
James Chung United States
Yuko Shirota
Citations per year, relative to Yuko Shirota Yuko Shirota (= 1×) peers James Chung

Countries citing papers authored by Yuko Shirota

Since Specialization
Citations

This map shows the geographic impact of Yuko Shirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Shirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Shirota more than expected).

Fields of papers citing papers by Yuko Shirota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Shirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Shirota. The network helps show where Yuko Shirota may publish in the future.

Co-authorship network of co-authors of Yuko Shirota

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Shirota. A scholar is included among the top collaborators of Yuko Shirota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Shirota. Yuko Shirota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shirai, Tsuyoshi, Tomonori Ishii, Yuko Shirota, et al.. (2025). Active withdrawal of corticosteroids using tocilizumab and its association with autoantibody profiles in relapsed Takayasu arteritis: a multicentre, single-arm, prospective study (the Ab-TAK study). Frontiers in Immunology. 15. 1473100–1473100. 1 indexed citations
3.
Hanaoka, Hironari, Akiyoshi Hashimoto, Yusho Ishii, et al.. (2025). A cohort study in HigAshi-nippon of Pulmonary hyPertensIoN in systEmic SclerosiS (HAPPINESS study): protocol and baseline data for an observational study. BMC Rheumatology. 9(1). 25–25.
4.
5.
6.
7.
Izumi, Rumiko, Naoki Suzuki, Yoshiki Takai, et al.. (2021). A rare case of sporadic inclusion body myositis and rheumatoid arthritis exhibiting ectopic lymphoid follicle-like structures: a case report and literature review. Neuromuscular Disorders. 31(9). 870–876. 2 indexed citations
8.
9.
Shirai, Tsuyoshi, Tomonori Ishii, Yuko Shirota, et al.. (2020). Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis. Nature Communications. 11(1). 1253–1253. 53 indexed citations
10.
11.
Shirota, Yuko, et al.. (2020). One after another retinal involvement in lupus. SHILAP Revista de lepidopterología. 8(2). 111–112. 1 indexed citations
12.
Ishii, Tomonori, Tsuyoshi Shirai, Yoko Fujita, et al.. (2019). Refractory Takayasu arteritis successfully treated with rituximab: case-based review. Rheumatology International. 39(11). 1989–1994. 16 indexed citations
13.
Ishii, Tomonori, Yoshiya Tanaka, Atsushi Kawakami, et al.. (2018). Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus. Modern Rheumatology. 28(6). 986–992. 54 indexed citations
14.
Fujii, Hiroshi, Masato Nose, Tsuyoshi Shirai, et al.. (2017). Bortezomib treatment induces a higher mortality rate in lupus model mice with a higher disease activity. Arthritis Research & Therapy. 19(1). 187–187. 11 indexed citations
15.
Watanabe, Ryu, Tomonori Ishii, Yoko Fujita, et al.. (2015). Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors. Modern Rheumatology. 26(1). 115–120. 34 indexed citations
16.
Shirai, Tsuyoshi, Hiroshi Fujii, Masao Ono, et al.. (2013). A novel autoantibody against ephrin type B receptor 2 in acute necrotizing encephalopathy. Journal of Neuroinflammation. 10(1). 128–128. 17 indexed citations
17.
Shirota, Yuko, Cheryl Yarboro, Randy Fischer, et al.. (2012). Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 72(1). 118–128. 98 indexed citations
18.
Shirota, Yuko, Chihiro Suzuki, Kenichi Ishizawa, et al.. (2010). Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis. International Journal of Hematology. 91(3). 501–508. 51 indexed citations
19.
Illei, Gabor G., Yuko Shirota, Cheryl Yarboro, et al.. (2010). Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study. Arthritis & Rheumatism. 62(2). 542–552. 386 indexed citations
20.
Shirota, Yuko, et al.. (2008). Biologic treatments for systemic rheumatic diseases. Oral Diseases. 14(3). 206–216. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Chung Breakdown of academic impact, for papers by Capucine Daridon Breakdown of academic impact, for papers by Marc Ittah Breakdown of academic impact, for papers by Şule Yavuz Breakdown of academic impact, for papers by Venkat Reddy Breakdown of academic impact, for papers by María Francisca González‐Escribano Breakdown of academic impact, for papers by Hideki Amuro Breakdown of academic impact, for papers by Jacob Aelion Breakdown of academic impact, for papers by Cornelia M. Weyand Breakdown of academic impact, for papers by Jens Thiel
Rankless by CCL
2026